APETF yields 718.80% · JNJ yields 2.13%● Live data
📍 APETF pulled ahead of the other in Year 1
Combined, APETF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of APETF + JNJ for your $10,000?
AlphaGen Intelligence Corp. operates as a game and software development company in North America and internationally. It holds a portfolio of assets in gaming, generative AI, technology, and content production services. The company owns and operates Shape, a metaverse studio, which builds the future of web3 gaming experiences and supporting companies as their metaverse partner to design and build leading brand and virtual retail experiences; MANA, a white-label SaaS solution that allows brands and other organizations to launch their own gaming platforms without having to fund technological or backend systems; and GamerzArena, a gaming platform that provides an esports ecosystem for all gamers that provides video game contests where gamers can compete for cash and prizes in leadership and bracket formats. AlphaGen Intelligence Corp. has a strategic partnership with XCAVE Studios Inc. to develop next-generation branded experiences in Fortnite. The company was formerly known as Alpha Metaverse Technologies Inc. and changed its name to AlphaGen Intelligence Corp. in June 2023. The company was incorporated in 2019 and is based in Vancouver, Canada.
Full APETF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.